Claudin 6 expression is useful to distinguish myxofibrosarcomas from other myxoid soft tissue tumors.

[1]  X. Tian,et al.  Delocalized Claudin-1 promotes metastasis of human osteosarcoma cells. , 2015, Biochemical and biophysical research communications.

[2]  N. Benvenisty,et al.  Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells , 2013, Nature Communications.

[3]  A. Yu,et al.  Claudins and the modulation of tight junction permeability. , 2013, Physiological reviews.

[4]  M. Fukayama,et al.  Distinct expression pattern of claudin‐6, a primitive phenotypic tight junction molecule, in germ cell tumours and visceral carcinomas , 2012, Histopathology.

[5]  J. Biegel,et al.  Claudin-6 is a Nonspecific Marker for Malignant Rhabdoid and Other Pediatric Tumors , 2012, The American journal of surgical pathology.

[6]  N. Wake,et al.  Nuclear localization of E‐cadherin but not beta‐catenin in human ovarian granulosa cell tumours and normal ovarian follicles and ovarian stroma , 2011, Histopathology.

[7]  P. Dhawan,et al.  Claudin Family of Proteins and Cancer: An Overview , 2010, Journal of oncology.

[8]  A. Flanagan,et al.  GNAS1 mutations occur more commonly than previously thought in intramuscular myxoma , 2009, Modern Pathology.

[9]  Rainer Breitling,et al.  RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis , 2006, Bioinform..

[10]  Y. Soini.  Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours , 2005, Histopathology.

[11]  Jeong-Won Lee,et al.  Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia. , 2005, Gynecologic oncology.

[12]  Rainer Breitling,et al.  Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments , 2004, FEBS letters.

[13]  C. Kong,et al.  Nodular Fasciitis , 2004, Acta Cytologica.

[14]  Takeshi Iwamura,et al.  Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. , 2003, Cancer research.

[15]  Kathleen R. Cho,et al.  Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  K. Turksen,et al.  Claudin‐6: A novel tight junction molecule is developmentally regulated in mouse embryonic epithelium , 2001, Developmental dynamics : an official publication of the American Association of Anatomists.

[17]  C. Fletcher,et al.  Cellular myxoma of soft tissue: a clinicopathological study of 38 cases confirming indolent clinical behaviour , 2001, Histopathology.

[18]  K. Fujimoto,et al.  Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. O'Connell,et al.  Intramuscular myxoma: a clinicopathologic study of 51 cases with emphasis on hypercellular and hypervascular variants. , 1998, The American journal of surgical pathology.

[20]  M. A. Smith,et al.  Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. , 1996, The American journal of surgical pathology.

[21]  J. Coindre,et al.  Soft‐tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system , 1984, International journal of cancer.

[22]  C. Fletcher,et al.  WHO classification of tumours of soft tissue and bone , 2013 .

[23]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.